RxDoctor Payments Data

Santosh Maharjan, MD

Psychiatry · Warsaw, INNPI 1073751616

Payments from drug & device makers

$2,873in general payments, 2019–2025

Across 195 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$853
  • Lundbeck LLC$336
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$295
  • AbbVie$259
  • Alkermes, Inc.$233
  • Neurocrine Biosciences, Inc.$217
  • plus $680 from 10 others

What the payments were for

  • Food & beverage$2,873100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,873 in reported general payments places this provider in the 80th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana

Medicare billing

Part B allowed, 2024
$21,838
Medicare patients
37
Services billed
289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate107$322,651
Abilify MaintenaAripiprazole34$89,651
AristadaAripiprazole Lauroxil14$48,151
RexultiBrexpiprazole19$28,702
TrintellixVortioxetine Hydrobromide33$14,937
Clozapine35$4,430
Paliperidone ErPaliperidone32$3,698
Divalproex Sodium ErDivalproex Sodium71$3,272
Divalproex Sodium43$2,865
Haloperidol Decanoate44$2,704
Aripiprazole68$2,638
Oxcarbazepine44$2,314
Olanzapine96$1,724
Hydroxyzine Hcl86$1,723
Haloperidol51$1,679

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$31$322,651107 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$853$118,35353 claims
Alkermes, Inc.Aristada$233$48,15114 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$16$14,93733 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 514 psychiatry providers in Indiana.

Other psychiatry in Warsaw

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →